Stockreport

NIAID reports preliminary data from trial of SIGA's Mpox treatment [Yahoo! Finance]

SIGA Technologies Inc.  (SIGA) 
US:NASDAQ Investor Relations: investor.siga.com/investor-relations
PDF from the PALM 007 clinical trial of SIGA Technologies' tecovirimat in treating monkeypox virus (Mpox). The placebo-controlled, randomised, double-blind trial assessed [Read more]